BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30694527)

  • 1. TRIM28 haploinsufficiency predisposes to Wilms tumor.
    Diets IJ; Hoyer J; Ekici AB; Popp B; Hoogerbrugge N; van Reijmersdal SV; Bhaskaran R; Hadjihannas M; Vasileiou G; Thiel CT; Seven D; Uebe S; Ilencikova D; Waanders E; Mavinkurve-Groothuis AMC; Roeleveld N; de Krijger RR; Wegert J; Graf N; Vokuhl C; Agaimy A; Gessler M; Reis A; Kuiper RP; Jongmans MCJ; Metzler M
    Int J Cancer; 2019 Aug; 145(4):941-951. PubMed ID: 30694527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutations and somatic inactivation of TRIM28 in Wilms tumour.
    Halliday BJ; Fukuzawa R; Markie DM; Grundy RG; Ludgate JL; Black MA; Skeen JE; Weeks RJ; Catchpoole DR; Roberts AGK; Reeve AE; Morison IM
    PLoS Genet; 2018 Jun; 14(6):e1007399. PubMed ID: 29912901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study.
    Armstrong AE; Gadd S; Huff V; Gerhard DS; Dome JS; Perlman EJ
    PLoS One; 2018; 13(12):e0208936. PubMed ID: 30543698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new Wilms tumour predisposition genes: an exome sequencing study.
    Mahamdallie S; Yost S; Poyastro-Pearson E; Holt E; Zachariou A; Seal S; Elliott A; Clarke M; Warren-Perry M; Hanks S; Anderson J; Bomken S; Cole T; Farah R; Furtwaengler R; Glaser A; Grundy R; Hayden J; Lowis S; Millot F; Nicholson J; Ronghe M; Skeen J; Williams D; Yeomanson D; Ruark E; Rahman N
    Lancet Child Adolesc Health; 2019 May; 3(5):322-331. PubMed ID: 30885698
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Moore C; Monforte H; Teer JK; Zhang Y; Yoder S; Brohl AS; Reed DR
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32699065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM28 variants and Wilms' tumour predisposition.
    Hol JA; Diets IJ; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MC; Kuiper RP
    J Pathol; 2021 Jul; 254(4):494-504. PubMed ID: 33565090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants.
    Wegert J; Fischer AK; Palhazi B; Treger TD; Hilgers C; Ziegler B; Jung H; Jüttner E; Waha A; Fuchs J; Warmann SW; Frühwald MC; Hubertus J; Pritchard-Jones K; Graf N; Behjati S; Furtwängler R; Gessler M; Vokuhl C
    J Pathol; 2024 Jan; 262(1):10-21. PubMed ID: 37792584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
    Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
    Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
    Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilms tumour resulting from paternal transmission of a TRIM28 pathogenic variant-A first report.
    Whitworth J; Armstrong R; Maher ER
    Eur J Hum Genet; 2024 Mar; 32(3):361-364. PubMed ID: 38282073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14.
    Perotti D; De Vecchi G; Testi MA; Lualdi E; Modena P; Mondini P; Ravagnani F; Collini P; Di Renzo F; Spreafico F; Terenziani M; Sozzi G; Fossati-Bellani F; Radice P
    Hum Mutat; 2004 Nov; 24(5):400-7. PubMed ID: 15459955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.
    Palculict TB; Ruteshouser EC; Fan Y; Wang W; Strong L; Huff V
    J Med Genet; 2016 Jun; 53(6):385-8. PubMed ID: 26566882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P; Telzerow P; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilms tumor genes.
    Huff V; Saunders GF
    Biochim Biophys Acta; 1993 Dec; 1155(3):295-306. PubMed ID: 8268188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity at 11p13 and 11p15 in Wilms tumor: a study of 22 cases from India.
    Sigamani E; Wari MN; Iyer VK; Agarwala S; Sharma A; Bakhshi S; Dinda A
    Pediatr Surg Int; 2013 Mar; 29(3):223-7. PubMed ID: 23292539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel CTR9 germline mutation in a family with Wilms tumor.
    Martins AG; Pinto AT; Domingues R; Cavaco BM
    Eur J Med Genet; 2018 May; 61(5):294-299. PubMed ID: 29292210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.
    Murphy AJ; Cheng C; Williams J; Shaw TI; Pinto EM; Dieseldorff-Jones K; Brzezinski J; Renfro LA; Tornwall B; Huff V; Hong AL; Mullen EA; Crompton B; Dome JS; Fernandez CV; Geller JI; Ehrlich PF; Mulder H; Oak N; Maciezsek J; Jablonowski CM; Fleming AM; Pichavaram P; Morton CL; Easton J; Nichols KE; Clay MR; Santiago T; Zhang J; Yang J; Zambetti GP; Wang Z; Davidoff AM; Chen X
    Nat Commun; 2023 Dec; 14(1):8006. PubMed ID: 38110397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour.
    Hanks S; Perdeaux ER; Seal S; Ruark E; Mahamdallie SS; Murray A; Ramsay E; Del Vecchio Duarte S; Zachariou A; de Souza B; Warren-Perry M; Elliott A; Davidson A; Price H; Stiller C; Pritchard-Jones K; Rahman N
    Nat Commun; 2014 Aug; 5():4398. PubMed ID: 25099282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.